Liu M, Liu Z, Leng Y, Zhang Q, et al. ZSP1601 is a non-selective phosphodiesterase inhibitor and a clinical drug candidate for the oral treatment of metabolic dysfunction-associated steatohepatitis. Biochem Biophys Res Commun 2026;839:154684.
PMID: 42837811